CASE REPORT
An unexpected leprosy diagnosis in Nordic patient with skin lesions
 
More details
Hide details
1
Department of Pathology, Innlandet Hospital, Lillehammer, Norway
 
2
Department of Microbiology, Innlandet Hospital, Lillehammer, Norway
 
 
Publication date: 2026-02-23
 
 
Corresponding author
Arnhild Binde
Arnhild Binde Department of Pathology Innlandet Hospital P.O. Box 990 2629 Lillehammer, Norway
 
 
Pol J Pathol 2025;76(4):355-359
 
KEYWORDS
ABSTRACT
Leprosy is a rare chronic infectious disease that can be challenging to diagnose in non-endemic settings due to limited clinical experience among physicians and its marked clinical heterogeneity. We report the case of leprosy in a Nordic patient with an extensive travel history who presented with cutaneous lesions, nasal congestion, and peripheral neurological symptoms. Although the histopathological findings were not fully specific, modified Ziehl-Neelsen staining revealed numerous acid-fast bacilli within the tissue samples. Mycobacterium leprae was subsequently confirmed by molecular analyses. To minimise diagnostic delay and prevent disease progression, we provide an overview of the histopathological features of leprosy and discuss relevant differential diagnoses.
REFERENCES (13)
1.
Smith CS, Aerts A, Saunderson P, Kawuma J, Kita E, Virmond M. Multidrug therapy for leprosy: a game changer on the path to elimination. Lancet Infect Dis 2017; 17: e293-e297.
 
2.
Lockwood N, McIntosh D, Armstrong AL, Checkley AM, Wal-ker SL, McBride A. Diagnosing and treating leprosy in a non- endemic setting in a national centre, London, United Kingdom 1995–2018. PLoS Negl Trop Dis 2022; 16: e0010799-e0010799.
 
3.
Pattyn SR. The problem of cultivation of Mycobacterium leprae. A review with criteria for evaluating recent experimental work. Bull World Health Organ 1973; 49: 403-410.
 
4.
World Health Organization. Leprosy – number of new leprosy cases: Available from: https://apps.who.int/neglected... (accessed: 29.10.2023).
 
5.
Guidelines for the diagnosis, treatment and prevention of leprosy. PAHO/WHO | Pan American Health Organization. 2018. Available from: https://www.paho.org/en/docume....
 
6.
Maymone MBC, Laughter M, Venkatesh S, Dacso MM,  Rao PN, Stryjewska BM, et al. Leprosy: clinical aspects and diagnostic techniques. J Am Acad Dermatol 2020; 83: 1-14.
 
7.
Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966; 34: 255-273.
 
8.
Massone C, Belachew WA, Schettini A. Histopathology of the lepromatous skin biopsy. Clin Dermatol 2014; 33: 38-45.
 
9.
Grijsen ML, Nguyen TH, Pinheiro RO, Singh P, Lambert SM, Walker SL, et al. Leprosy. Nature Rev Dis Prim 2024; 10: 90.
 
10.
Cogen AL, Lebas E, De Barros B, Harnisch JP, Faber WR, Lockwood DN, et al. Biologics in leprosy: a systematic review and case report. Am J Trop Med Hyg 2020; 102: 1131-1136.
 
11.
Sardana K, Sharath S, Khurana A. Misdiagnosis of leprosy: an underappreciated reason for its continued prevalence. Indian J Med Res 2025; 161: 5-8.
 
12.
World Health Organization: WHO. Leprosy WPRO. 2018. Available from: https://www.who.int/westernpac....
 
13.
Martinez AN, Talhari C, Moraes MO, Talhari S. PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic. PLoS Negl Trop Dis 2014; 8: e2655.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top